Search results
OPKO Health Inc (OPK) Q1 2024 Earnings Call Transcript Highlight
Guru Focus· 6 days agoAsset Sale: Agreement to sell Bio-Reference health assets to LabCorp for $237.5 million.Revenue: Q1 2024 revenue for Diagnostics segment reported at $126.9 mil
Catalyst (CPRX) Q1 Earnings Beat, Firdapse Sales Drive Revenues
Zacks via Yahoo Finance· 4 days agoSome better-ranked stocks from the drug/biotech industry are ...LGND, ANI Pharmaceuticals ANIP and...
Mirum's (MIRM) Q1 Earnings & Revenues Fall Shy of Estimates
Zacks· 4 days agoMirum's (MIRM) earnings and revenues miss estimates in the first quarter of 2024. Livmarli drives year-over-year sales.
OPKO Health Inc (OPK) Q1 2024 Earnings Call Transcript Highlights: Strategic Moves Amid ...
GuruFocus.com via Yahoo Finance· 5 days agoAsset Sale: Agreement to sell Bio-Reference health assets to LabCorp for $237.5 million. Revenue...outstanding shares by over 7%. Cost of Expenses: Decreased to $161.
Annovis Bio CEO Maria Maccecchini Issues Letter to Stockholders - Annovis Bio (NYSE:ANVS)
Benzinga· 7 days agoAnnovis Bio, Inc. ANVS ("Annovis" or the "Company"), a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases, announced that Maria ...
First sickle cell patient begins bluebird gene therapy treatment - Boston Business Journal
The Business Journals· 7 days agoFive months after bluebird bio Inc. won FDA approval for its gene therapy to treat sickle cell...
SkyWater Technology Inc (SKYT) Reports Mixed Q1 2024 Results, Mi
Guru Focus· 3 days agoRevenue: Reported $79.6 million, up 20% year-over-year, slightly below estimates of $80.00 million.Net Loss: Increased to $5.7 million from $4.3 million in Q1
Nu Skin Enterprises Inc (NUS) (Q1 2024) Earnings Call Transcript
Guru Focus· 5 days agoFor the complete transcript of the earnings call, please refer to the full earnings call transcript. The company's RISE business segment showed strong performance with a 57% ...
Century-Old Chemistry Puzzle Solved: Researchers Unveils Game-Changing Compound
SciTechDaily· 5 days agoFor decades, researchers have been investigating molecules called N-heteroarenes, which are...
Intellia's (NTLA) Q1 Earnings & Revenues Beat Estimates
Zacks· 3 days agoIntellia's (NTLA) earnings and revenues surpass estimates in the first quarter of 2024. The company provides developmental and regulatory updates on its pipeline candidates. Stock rises.